Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Janssen

“The top priority target for vaccines is around 1 million…from high-risk groups such as medical staff and the elderly” (General)

“The top priority target for vaccines is around 1 million…from high-risk groups such as medical staff and the elderly” (General)

[서울신문] Pfizer, 95% prevention effect’best’…  Janssen and AstraZeneca have side effects such as nervous system

[서울신문] Pfizer, 95% prevention effect’best’… Janssen and AstraZeneca have side effects such as nervous system

Astra Janssen vaccine is’in clinical trial’…  ‘It seems difficult to complete vaccination before the end of next year’

Astra Janssen vaccine is’in clinical trial’… ‘It seems difficult to complete vaccination before the end of next year’

Janssen, who comes to Korea in the second quarter of next year, only needs one shot, unlike other vaccines

Janssen, who comes to Korea in the second quarter of next year, only needs one shot, unlike other vaccines

[속보] Janssen starts vaccination in the second quarter of next year…  Pfizer third quarter earnings

[속보] Janssen starts vaccination in the second quarter of next year… Pfizer third quarter earnings

The Ministry of Food and Drug Safety begins preliminary review of Janssen’s Corona 19 vaccine

The Ministry of Food and Drug Safety begins preliminary review of Janssen’s Corona 19 vaccine

Janssen Vaccine Announces Third Commercialization…  What is the share price of related domestic stocks?

Janssen Vaccine Announces Third Commercialization… What is the share price of related domestic stocks?

Newer posts
← Previous Page1 Page2 Page3

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en